FindTrial
Sign In

Assessing the utility of individualized homoeopathic medicine in the management of Adenoid Hypertrophy in children

Assessing the utility of individualized homoeopathic medicine in the management of Adenoid Hypertrophy in children A Prospective Single Arm Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104797
Enrollment
30
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: Patients qualifying to inclusion criteria will be included in the study. Proper case taking of all enrolled patients will be done in standardized c

Sponsors

Dr Megha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 3 to 10 years Clinically diagnosed adenoid hypertrophy, with symptoms like snoring, mouth breathing, nasal obstruction. Radiologically confirmed adenoidal nasopharyngeal ratio is more than 0.5 Parents willing to opt for nonsurgical homeopathic management Informed consent obtained from guardians or legally authorized representative

Exclusion criteria

Exclusion criteria: Cases needing emergency adenoidectomy or with severe obstructive sleep apnea complications i.e. adenoidal nasopharyngeal ratio more than 0.75 Structural deformities e.g., DNS, cleft palate, nasal polyps Immunodeficiencies or chronic systemic diseases Children with psychiatric and behavioral issues. Refusal to participate or noncompliance with treatment or follow up Concurrent treatment from other medical systems targeting adenoid hypertrophy Previous history of adenoidectomy

Design outcomes

Primary

MeasureTime frame
TO EVALUATE THE EFFECTS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE USING THE ADENOIDAL NASOPHARYNGEAL RATIOTimepoint: 3 MONTHS—

Secondary

MeasureTime frame
TO EVALUATE THE EFFECTS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE USING THE NOSE SCORETimepoint: 6 MONTHS—

Countries

India

Contacts

Public ContactDr. Megha

State National Homoeopathic Medical College and Hospital Lucknow

gyanprakash3916@gmail.com9839260828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026